Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lophos Holdings Inc C.MESC

Lophos Holdings Inc. is a Canada-based company, which is engaged in the cultivation and research of Lophophora williamsii (peyote cactus). The Company is also engaged in the research and development of compounds derived from the peyote cactus. The Company's cultivated peyote cactus will be used by the Company to conduct pre-clinical research and development in Canada either directly through a... see more

Recent & Breaking News (CSE:MESC)

    Lophos Pharmaceuticals Corp. Receives Traditional Blessing for Napanee Site in Honor of Indigenous Heritage

    Newsfile May 15, 2024

    Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com

    GlobeNewswire May 6, 2024

    Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol

    GlobeNewswire May 2, 2024

    Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds

    GlobeNewswire April 25, 2024

    Lophos Pharmaceuticals' Licensed Site Celebrates Successful Building Occupancy

    GlobeNewswire April 17, 2024

    ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.

    GlobeNewswire April 15, 2024

    ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership

    GlobeNewswire April 15, 2024

    Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan

    GlobeNewswire March 28, 2024

    Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy

    GlobeNewswire March 5, 2024

    Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting

    GlobeNewswire February 28, 2024

    Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)

    GlobeNewswire February 14, 2024

    Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol

    GlobeNewswire February 8, 2024

    Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)

    GlobeNewswire January 31, 2024

    Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation

    GlobeNewswire January 23, 2024

    Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions

    GlobeNewswire November 21, 2023

    Canadian Securities Exchange Reports September 2023 Performance Figures

    Newsfile October 25, 2023

    Lophos Secures Game-Changing Controlled Substance Dealer's License with the Expertise of Canalytica Corp.

    GlobeNewswire October 10, 2023

    Lophos Opens Early Enrollment for Peyote Sales and Appoints Market Maker

    GlobeNewswire September 19, 2023